Clinical trial
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic…
NCT00304538 · DiObex, Industry · Completed
Key facts
| NCT number | NCT00304538 |
|---|---|
| Title | A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus |
| Official title | A Phase 1b, Single-Blind Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Three Separate Dose Levels of Very Low Dose-Glucagon Administered Subcutaneously Overnight for 6, 9 or 12 Hours in Subjects With Type 1 Diabetes Mellitus |
| Lead sponsor | DiObex, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | very low dose (VLD) glucagon |
| Enrollment | 10 |
| Start date | Mar 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Mar 20, 2006 |
| Last update posted | Aug 23, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: